The NIMH-MATRICS Consensus Statement on Negative Symptoms

Overview

Journal Schizophr Bull

Publisher Oxford University Press

Specialty Psychiatry

Date 2006 Feb 17

PMID 16481659

Citations 458

Authors

Brian Kirkpatrick

Wayne S Fenton

William T Carpenter Jr

Stephen R Marder

Affiliations

Soon will be listed here.

Citing Articles

Systematic Review of Self-Assessment Scales for Negative Symptoms in Schizophrenia.

Metivier L, Dollfus S Brain Sci. 2025; 15(2).

PMID: 40002481 PMC: 11852625. DOI: 10.3390/brainsci15020148.

Striatal dopamine D2/D3 receptor regulation of human reward processing and behaviour.

Osugo M, Wall M, Selvaggi P, Zahid U, Finelli V, Chapman G Nat Commun. 2025; 16(1):1852.

PMID: 39984436 PMC: 11845780. DOI: 10.1038/s41467-025-56663-7.

Assessment of Negative Symptoms in Schizophrenia: From the Consensus Conference-Derived Scales to Remote Digital Phenotyping.

Mucci A, Leucht S, Giordano G, Giuliani L, Wehr S, Weigel L Brain Sci. 2025; 15(1).

PMID: 39851450 PMC: 11764445. DOI: 10.3390/brainsci15010083.

Dutch Validation of the Self-Evaluation of Negative Symptoms Scale (SNS).

van Brouwershaven T, Poppe A, Pijnenborg G, Aleman A, Boonstra N, Gangadin S Brain Sci. 2025; 15(1).

PMID: 39851383 PMC: 11763429. DOI: 10.3390/brainsci15010015.

Predicting clinical outcomes in a blended care intervention for early psychosis: Acceptance and Commitment Therapy in Daily-Life (ACT-DL).

Bonnier R, Beames J, Kiekens G, van Aubel E, Schirmbeck F, de Haan L Transl Psychiatry. 2025; 15(1):3.

PMID: 39774720 PMC: 11707341. DOI: 10.1038/s41398-024-03214-1.

References

Carpenter Jr W, Heinrichs D, Wagman A . Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry. 1988; 145(5):578-83. DOI: 10.1176/ajp.145.5.578. View

Erhart S, Marder S, Carpenter W . Treatment of schizophrenia negative symptoms: future prospects. Schizophr Bull. 2006; 32(2):234-7. PMC: 2632230. DOI: 10.1093/schbul/sbj055. View

Buchanan R, Carpenter W . Domains of psychopathology: an approach to the reduction of heterogeneity in schizophrenia. J Nerv Ment Dis. 1994; 182(4):193-204. View

Kirkpatrick B, Kopelowicz A, Buchanan R, Carpenter Jr W . Assessing the efficacy of treatments for the deficit syndrome of schizophrenia. Neuropsychopharmacology. 2000; 22(3):303-10. DOI: 10.1016/S0893-133X(99)00122-0. View

NORMAN R, Malla A, McLean T, Voruganti L, Cortese L, McIntosh E . The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the Quality of Life Scale. Acta Psychiatr Scand. 2000; 102(4):303-9. DOI: 10.1034/j.1600-0447.2000.102004303.x. View

Kirkpatrick B, Buchanan R, Ross D, Carpenter Jr W . A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry. 2001; 58(2):165-71. DOI: 10.1001/archpsyc.58.2.165. View

Katschnig H . Schizophrenia and quality of life. Acta Psychiatr Scand Suppl. 2001; (407):33-7. DOI: 10.1034/j.1600-0447.2000.00006.x. View

Orsel S, Akdemir A, Dag I . The sensitivity of quality-of-life scale WHOQOL-100 to psychopathological measures in schizophrenia. Compr Psychiatry. 2003; 45(1):57-61. DOI: 10.1016/j.comppsych.2003.09.006. View

Lysaker P, Davis L . Social function in schizophrenia and schizoaffective disorder: associations with personality, symptoms and neurocognition. Health Qual Life Outcomes. 2004; 2:15. PMC: 398420. DOI: 10.1186/1477-7525-2-15. View

10.

Strauss J, Carpenter Jr W, Bartko J . The diagnosis and understanding of schizophrenia. Part III. Speculations on the processes that underlie schizophrenic symptoms and signs. Schizophr Bull. 1974; (11):61-9. DOI: 10.1093/schbul/1.11.61. View

11.

Andreasen N . Negative symptoms in schizophrenia. Definition and reliability. Arch Gen Psychiatry. 1982; 39(7):784-8. DOI: 10.1001/archpsyc.1982.04290070020005. View

12.

Berrios G . Positive and negative symptoms and Jackson. A conceptual history. Arch Gen Psychiatry. 1985; 42(1):95-7. DOI: 10.1001/archpsyc.1985.01790240097011. View

13.

Kay S, Fiszbein A, Opler L . The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987; 13(2):261-76. DOI: 10.1093/schbul/13.2.261. View

14.

Kirkpatrick B, Fischer B . Subdomains within the negative symptoms of schizophrenia: commentary. Schizophr Bull. 2006; 32(2):246-9. PMC: 2632226. DOI: 10.1093/schbul/sbj054. View

15.

Kirkpatrick B, Buchanan R, McKenney P, Alphs L, Carpenter Jr W . The Schedule for the Deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res. 1989; 30(2):119-23. DOI: 10.1016/0165-1781(89)90153-4. View

16.

Green M . What are the functional consequences of neurocognitive deficits in schizophrenia?. Am J Psychiatry. 1996; 153(3):321-30. DOI: 10.1176/ajp.153.3.321. View

17.

Leucht S, Pitschel-Walz G, Abraham D, Kissling W . Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials. Schizophr Res. 1999; 35(1):51-68. DOI: 10.1016/s0920-9964(98)00105-4. View

18.

Lysaker P, Lancaster R, Nees M, Davis L . Attributional style and symptoms as predictors of social function in schizophrenia. J Rehabil Res Dev. 2004; 41(2):225-32. DOI: 10.1682/jrrd.2004.02.0225. View

19.

Wegener S, Redoblado-Hodge M, Lucas S, Fitzgerald D, Harris A, Brennan J . Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis. Aust N Z J Psychiatry. 2005; 39(6):487-92. DOI: 10.1080/j.1440-1614.2005.01608.x. View

20.

Green M, Olivier B, Crawley J, Penn D, Silverstein S . Social cognition in schizophrenia: recommendations from the measurement and treatment research to improve cognition in schizophrenia new approaches conference. Schizophr Bull. 2005; 31(4):882-7. DOI: 10.1093/schbul/sbi049. View